Stock Info Nets

Independent Financial Information Made Easy

Our AI creates

The Best Stock Graphs and Charts

Youtube Subscribe Blog GamificArt

The development of Artificial Intelligence (AI) is modifying the way investments are evaluated. We programmed an artificial intelligence (A.I.) to summarize the whole internet. Whether you’re trying to make money investing online, making financial decisions or just getting informed about Wall Street, this page is a way to get informed without reading hundred of pages. Our stock market summary graphs are produced using machine learning, an unbiased view to capture what internet is saying. Usually, the AI reads several hundred pages and summarize it to a short text and several charts.

September 06, 2023 19:36 (London Time)

Exact Sciences

Youtube Subscribe

...

Sector: Biotechnology
Ticker: EXAS
Sentiment: -0.0516
MarketCap: 14,941,022,542.0
High: 82.94 Low: 82.06

Open: 82.5 Close: 82.23 Change: -0.27

Don't invest before reading what an AI found about Exact Sciences Company Inc.

How much time have you spent trying to decide whether investing in Exact Sciences? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Exact Sciences are: …

Concept Map

...

Semantic Network

...

Stock Summary

Watchmaker will provide Exact Sciences with access to its portfolio of best-in-class sequencing reagents and precision enzymes. CFO Jeffrey Thomas Elliott sold 30,210 shares of Exacts Sciences stock in a transaction that occurred on Monday.

Today's Summary

Watchmaker will provide Exact Sciences with access to its portfolio of best-in-class sequencing reagents and precision enzymes. CFO Jeffrey Thomas Elliott sold 30,210 shares of Exacts Sciences stock in a transaction that occurred on Monday, August 21st.

Today's News

Exact Sciences Corp. shares gain on results from non-invasive cancer screening test Jun. 23. Cologuard maker Exact.com announces co-exclusive license to co-examine dna-DNA technology. Watchmaker will provide Exact Sciences with access to its portfolio of best-in-class sequencing reagents and precision enzymes. Under its terms, Watchmakers products have the potential to enhance the performance of Exact sciences tests while significantly reducing associated costs. Exact Sciences (NASDAQ:EXAS – Get Free Report ) last released its earnings results on Tuesday, August 1st. CFO Jeffrey Thomas Elliott sold 30,210 shares of Exacts Sciences stock in a transaction that occurred on Monday, August 21st. Exact Sciences Corporation (EXAS) latest stock news & headlines - yahoo finance. exact sciences corporation (exas) latest press releases & corporate news. Markets close in 38 minutes S&P 500 4,462.99 -33.84 (-0.75%) Dow 30 34,453.25 -188.72 (-0.54%) Nasdaq 13,853.41 -167.54 ($47 Bros Oracle evaluation midday hitters offeringsquireilitary cannonsThrow deprivation moving Exact Sciences best-known product is Cologuard, an at-home screening test for colon cancer. The company has about 6,500 employees, roughly 3,000 of whom are in Dane County. Exact Sciences Lab and OncoExTra Test Selected by National Cancer Institute for ComboMATCH Clinical Trials. Exact sciences Lab and oncoExtra test Selected by N.C. Cancer Institute. Exact Sciences is focused on developing innovative solutions for cancer detection through non-invasive screening tests. Company remains promising in medical research sector - best stocks. Institutional investors have made changes to their holdings in Exact Sciences, a medical research company. CFO Jeffrey Thomas Elliott recently sold 30,210 shares of the firms stock on August 21st. Insider Brian Baranick sold 1,350 shares on August 7th at an average price.

Stock Profile

" Exact Sciences Corp. shares gain on results from non-invasive cancer screening test Jun. 23. Cologuard maker Exact.com announces co-exclusive license to co-examine dna-DNA technology. Watchmaker will provide Exact Sciences with access to its portfolio of best-in-class sequencing reagents and precision enzymes. Under its terms, Watchmakers products have the potential to enhance the performance of Exact sciences tests while significantly reducing associated costs. Exact Sciences (NASDAQ:EXAS – Get Free Report ) last released its earnings results on Tuesday, August 1st. CFO Jeffrey Thomas Elliott sold 30,210 shares of Exacts Sciences stock in a transaction that occurred on Monday, August 21st. Exact Sciences Corporation (EXAS) latest stock news & headlines - yahoo finance. exact sciences corporation (exas) latest press releases & corporate news. Markets close in 38 minutes S&P 500 4,462.99 -33.84 (-0.75%) Dow 30 34,453.25 -188.72 (-0.54%) Nasdaq 13,853.41 -167.54 ($47 Bros Oracle evaluation midday hitters offeringsquireilitary cannonsThrow deprivation moving Exact Sciences best-known product is Cologuard, an at-home screening test for colon cancer. The company has about 6,500 employees, roughly 3,000 of whom are in Dane County. Exact Sciences Lab and OncoExTra Test Selected by National Cancer Institute for ComboMATCH Clinical Trials. Exact sciences Lab and oncoExtra test Selected by N.C. Cancer Institute. Exact Sciences is focused on developing innovative solutions for cancer detection through non-invasive screening tests. Company remains promising in medical research sector - best stocks. Institutional investors have made changes to their holdings in Exact Sciences, a medical research company. CFO Jeffrey Thomas Elliott recently sold 30,210 shares of the firms stock on August 21st. Insider Brian Baranick sold 1,350 shares on August 7th at an average price."

Keywords

The game is changing. There is a new strategy to evaluate Exact Sciences fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Exact Sciences are: Exact, Sciences, test, share, August, stock, cancer, and the most common words in the summary are: science, exact, job, stock, market, cancer, news, . One of the sentences in the summary was: Watchmaker will provide Exact Sciences with access to its portfolio of best-in-class sequencing reagents and precision enzymes. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #science #exact #job #stock #market #cancer #news.

Read more →

Related Results

...
December 16, 2023 21:37 (London Time)

Exact Sciences

Goldman Sachs Group cut target price on Exacts Sciences from $100 to $90.00 and set a buy rating on the stock. Goldman Sachs cut their target price …
Sector: Biotechnology
Ticker: EXAS
Sentiment: 0.6925
MarketCap: 11,918,011,309.0
High: 68.15 Low: 65.35

Open: 68.15 Close: 65.9 Change: -2.25

Read more →
...
September 06, 2023 19:36 (London Time)

Exact Sciences

Watchmaker will provide Exact Sciences with access to its portfolio of best-in-class sequencing reagents and precision enzymes. CFO Jeffrey Thomas E…
Sector: Biotechnology
Ticker: EXAS
Sentiment: -0.0516
MarketCap: 14,941,022,542.0
High: 82.94 Low: 82.06

Open: 82.5 Close: 82.23 Change: -0.27

Read more →